Page last updated: 2024-09-03

t 0632 and gabexate

t 0632 has been researched along with gabexate in 1 studies

Compound Research Comparison

Studies
(t 0632)
Trials
(t 0632)
Recent Studies (post-2010)
(t 0632)
Studies
(gabexate)
Trials
(gabexate)
Recent Studies (post-2010) (gabexate)
60174353106

Protein Interaction Comparison

ProteinTaxonomyt 0632 (IC50)gabexate (IC50)
Solute carrier family 22 member 2Homo sapiens (human)0.9
Coagulation factor XHomo sapiens (human)4.61
PlasminogenHomo sapiens (human)0.431
Urokinase-type plasminogen activatorHomo sapiens (human)0.431
Serine protease hepsinHomo sapiens (human)0.383
Multidrug and toxin extrusion protein 1Homo sapiens (human)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, T; Kume, E; Nagasaki, M; Shikano, T; Taniguchi, H; Yomota, E1

Other Studies

1 other study(ies) available for t 0632 and gabexate

ArticleYear
Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Japanese journal of pharmacology, 1997, Volume: 73, Issue:2

    Topics: Acute Disease; Amylases; Animals; Ceruletide; Disease Models, Animal; Dogs; Esters; Female; Gabexate; Guanidines; Hormone Antagonists; Indoles; Ligation; Male; Pancreatic Ducts; Pancreatitis; Proglumide; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cholecystokinin A; Receptors, Cholecystokinin

1997